184 related articles for article (PubMed ID: 22320910)
1. Biological and clinical relevance of stem cells in pancreatic adenocarcinoma.
Rasheed ZA; Matsui W
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):15-8. PubMed ID: 22320910
[TBL] [Abstract][Full Text] [Related]
2. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy.
Mizukami T; Kamachi H; Mitsuhashi T; Tsuruga Y; Hatanaka Y; Kamiyama T; Matsuno Y; Taketomi A
BMC Cancer; 2014 Sep; 14():687. PubMed ID: 25240521
[TBL] [Abstract][Full Text] [Related]
4. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
[TBL] [Abstract][Full Text] [Related]
5. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity and targeting of pancreatic cancer stem cells.
Penchev VR; Rasheed ZA; Maitra A; Matsui W
Clin Cancer Res; 2012 Aug; 18(16):4277-84. PubMed ID: 22896694
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer stem cells: their role in pancreatic cancer patient outcomes and what is future?
Habib M; Saif MW
JOP; 2013 Jul; 14(4):401-4. PubMed ID: 23846937
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
[TBL] [Abstract][Full Text] [Related]
9. Nestin and other putative cancer stem cell markers in pancreatic cancer.
Matsuda Y; Kure S; Ishiwata T
Med Mol Morphol; 2012 Jun; 45(2):59-65. PubMed ID: 22718289
[TBL] [Abstract][Full Text] [Related]
10. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.
Jimeno A; Feldmann G; Suárez-Gauthier A; Rasheed Z; Solomon A; Zou GM; Rubio-Viqueira B; García-García E; López-Ríos F; Matsui W; Maitra A; Hidalgo M
Mol Cancer Ther; 2009 Feb; 8(2):310-4. PubMed ID: 19174553
[TBL] [Abstract][Full Text] [Related]
11. Isolation of stem cells from human pancreatic cancer xenografts.
Rasheed Z; Wang Q; Matsui W
J Vis Exp; 2010 Sep; (43):. PubMed ID: 20972397
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.
Rasheed ZA; Yang J; Wang Q; Kowalski J; Freed I; Murter C; Hong SM; Koorstra JB; Rajeshkumar NV; He X; Goggins M; Iacobuzio-Donahue C; Berman DM; Laheru D; Jimeno A; Hidalgo M; Maitra A; Matsui W
J Natl Cancer Inst; 2010 Mar; 102(5):340-51. PubMed ID: 20164446
[TBL] [Abstract][Full Text] [Related]
13. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications.
Gzil A; Zarębska I; Bursiewicz W; Antosik P; Grzanka D; Szylberg Ł
Mol Biol Rep; 2019 Dec; 46(6):6629-6645. PubMed ID: 31486978
[TBL] [Abstract][Full Text] [Related]
14. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
15. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer stem cells: features and detection methods.
Ishiwata T; Matsuda Y; Yoshimura H; Sasaki N; Ishiwata S; Ishikawa N; Takubo K; Arai T; Aida J
Pathol Oncol Res; 2018 Oct; 24(4):797-805. PubMed ID: 29948612
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer stem cell markers and exosomes - the incentive push.
Heiler S; Wang Z; Zöller M
World J Gastroenterol; 2016 Jul; 22(26):5971-6007. PubMed ID: 27468191
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
19. Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells.
Zhu Y; Karakhanova S; Huang X; Deng SP; Werner J; Bazhin AV
Exp Cell Res; 2014 Jun; 324(2):146-56. PubMed ID: 24726912
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer stem cells.
Lee CJ; Dosch J; Simeone DM
J Clin Oncol; 2008 Jun; 26(17):2806-12. PubMed ID: 18539958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
